Details
Stereochemistry | ACHIRAL |
Molecular Formula | C59H92O4 |
Molecular Weight | 865.3616 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 9 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(=CCC/C(=C(\[H])/CC/C(=C(\[H])/CC/C(=C(\[H])/CC/C(=C(\[H])/CC/C(=C(\[H])/CC/C(=C(\[H])/CC/C(=C(\[H])/CC/C(=C(\[H])/CC/C(=C(\[H])/Cc1c(C)c(c(c(c1O)OC)OC)O)/C)/C)/C)/C)/C)/C)/C)/C)/C)C
InChI
InChIKey=QNTNKSLOFHEFPK-UPTCCGCDSA-N
InChI=1S/C59H92O4/c1-44(2)24-15-25-45(3)26-16-27-46(4)28-17-29-47(5)30-18-31-48(6)32-19-33-49(7)34-20-35-50(8)36-21-37-51(9)38-22-39-52(10)40-23-41-53(11)42-43-55-54(12)56(60)58(62-13)59(63-14)57(55)61/h24,26,28,30,32,34,36,38,40,42,60-61H,15-23,25,27,29,31,33,35,37,39,41,43H2,1-14H3/b45-26+,46-28+,47-30+,48-32+,49-34+,50-36+,51-38+,52-40+,53-42+
UBIQUINOL is a reduced form of coenzyme Q10, a lipid-soluble molecule that consists of an aromatic ring and a 10-unit isoprenoid chain. It is naturally produced by the body. A significant increase in plasma CoQ10 status observed after supplementation in one study suggested that UBIQUINOL is a better supplemental form to enhance the CoQ10 status than ubiquinone (the oxidized form of Q10). UBIQUINOL has also been found to reduce oxidative stress induced by strenuous exercise. Oxidative stress is associated with aging and many chronic diseases, such as cardiovascular diseases, cancers, and cognitive decline. Ubiquinol has furthermore been shown to improve mitochondrial oxidative metabolism in the brain, and cognitive improvement was found as a result of Ubiquinol intake in chronic fatigue syndrome patients. UBIQUINOL is considered safe, but can have side effects such as upper abdominal pain, loss of appetite, nausea, diarrhea and headaches. CoQ10 might make blood-thinning drugs, such as warfarin (Coumadin, Jantoven), less effective. This could increase the risk of a blood clot.
Approval Year
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
EU-Orphan Drug |
EU/3/16/1765
Created by
admin on Sat Jun 26 04:52:17 UTC 2021 , Edited by admin on Sat Jun 26 04:52:17 UTC 2021
|
||
|
FDA ORPHAN DRUG |
179403
Created by
admin on Sat Jun 26 04:52:17 UTC 2021 , Edited by admin on Sat Jun 26 04:52:17 UTC 2021
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
SUB32843
Created by
admin on Sat Jun 26 04:52:17 UTC 2021 , Edited by admin on Sat Jun 26 04:52:17 UTC 2021
|
PRIMARY | |||
|
9962735
Created by
admin on Sat Jun 26 04:52:17 UTC 2021 , Edited by admin on Sat Jun 26 04:52:17 UTC 2021
|
PRIMARY | |||
|
C026663
Created by
admin on Sat Jun 26 04:52:17 UTC 2021 , Edited by admin on Sat Jun 26 04:52:17 UTC 2021
|
PRIMARY | |||
|
M9NL0C577Y
Created by
admin on Sat Jun 26 04:52:17 UTC 2021 , Edited by admin on Sat Jun 26 04:52:17 UTC 2021
|
PRIMARY | |||
|
UBIQUINOL
Created by
admin on Sat Jun 26 04:52:17 UTC 2021 , Edited by admin on Sat Jun 26 04:52:17 UTC 2021
|
PRIMARY | |||
|
DB11340
Created by
admin on Sat Jun 26 04:52:17 UTC 2021 , Edited by admin on Sat Jun 26 04:52:17 UTC 2021
|
PRIMARY | |||
|
1705334
Created by
admin on Sat Jun 26 04:52:17 UTC 2021 , Edited by admin on Sat Jun 26 04:52:17 UTC 2021
|
PRIMARY | USP-RS | ||
|
39085
Created by
admin on Sat Jun 26 04:52:17 UTC 2021 , Edited by admin on Sat Jun 26 04:52:17 UTC 2021
|
PRIMARY | RxNorm | ||
|
992-78-9
Created by
admin on Sat Jun 26 04:52:17 UTC 2021 , Edited by admin on Sat Jun 26 04:52:17 UTC 2021
|
PRIMARY |
ACTIVE MOIETY